BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15073182)

  • 1. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
    Zhang Y; Hamburger AW
    J Biol Chem; 2004 Jun; 279(25):26126-33. PubMed ID: 15073182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases.
    Zhang Y; Woodford N; Xia X; Hamburger AW
    Nucleic Acids Res; 2003 Apr; 31(8):2168-77. PubMed ID: 12682367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.
    Zhang Y; Akinmade D; Hamburger AW
    Nucleic Acids Res; 2005; 33(18):6024-33. PubMed ID: 16254079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
    Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
    J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBP1 is a novel E2F target gene regulated by transforming growth factor-β.
    Judah D; Chang WY; Dagnino L
    PLoS One; 2010 Nov; 5(11):e13941. PubMed ID: 21085677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.
    Akinmade D; Lee M; Zhang Y; Hamburger AW
    Int J Oncol; 2007 Oct; 31(4):851-8. PubMed ID: 17786317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.
    Zhang Y; Fondell JD; Wang Q; Xia X; Cheng A; Lu ML; Hamburger AW
    Oncogene; 2002 Aug; 21(36):5609-18. PubMed ID: 12165860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.
    Lessor TJ; Hamburger AW
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):185-91. PubMed ID: 11325528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F site activates transcription in fission yeast Schizosaccharomyces pombe and binds to a 30-kDa transcription factor.
    Malhotra P; Manohar CF; Swaminathan S; Toyama R; Dhar R; Reichel R; Thimmapaya B
    J Biol Chem; 1993 Sep; 268(27):20392-401. PubMed ID: 8376397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
    Zhang Y; Akinmade D; Hamburger AW
    Cancer Lett; 2008 Jul; 265(2):298-306. PubMed ID: 18355957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation.
    Lavrrar JL; Farnham PJ
    J Biol Chem; 2004 Oct; 279(44):46343-9. PubMed ID: 15328355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.
    Zhang Y; Hamburger AW
    Br J Cancer; 2005 Jan; 92(1):140-6. PubMed ID: 15583694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
    Koziczak M; Müller H; Helin K; Nagamine Y
    Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
    Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
    J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.
    Jordan KL; Evans DL; Steelman S; Hall DJ
    Biochemistry; 1996 Sep; 35(38):12320-8. PubMed ID: 8823166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1.
    Blais A; Monté D; Pouliot F; Labrie C
    J Biol Chem; 2002 Aug; 277(35):31679-93. PubMed ID: 12077144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.